Please assess the completion status of the following clinical trial:

Trial Title: Role of Circulating Innate Lymphoid Cells in Allergic Disorders

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: CROSS_SECTIONAL
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Adult subjects between age 19-50 years.~2. Non-smokers, defined as \< 100 cigarettes in lifetime.~Exclusion Criteria:~1. Female donors will be excluded if they are menopausal or have undergone total abdominal hysterectomy and/or bilateral salpingoophorectomy~2. For female donors, blood draw cannot occur during menstrual period time. Subjects will be excluded if they have menstrual period at timing of blood draw.~3. Current and past smokers.~4. Subjects with asthma and any other lung disease including chronic obstructive pulmonary disease, interstitial lung disease, pulmonary hypertension, sarcoidosis, cystic fibrosis.~5. Pregnant or lactating subjects~6. Subjects with hypercalcemia (\> 10.3 mg/dL), renal insufficiency (glomerular filtration rate \[GFR\] \< 50 mL/min/1.73m2), or malignancy.~7. Subjects with any symptoms of respiratory infection in the past 4 weeks.~8. Subjects unable to hold leukotriene modifiers or antihistamines for at least 24 hours prior to blood draw.~9. Subjects on any immunomodulators, including omalizumab, or systemic corticosteroid in the past 4 weeks.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Healthy Control Adult Subjects (Type: None): Healthy adult subjects between the ages of 19-50 years will be enrolled.
- Asthmatic Adult Subjects (Type: None): Adult subjects between the ages of 19-50 years with mild-to-moderate asthma seen within the UNMC Allergy and Pulmonary Clinics will be invited to be enrolled.
- Chronic Urticaria Adult Subjects (Type: None): Adult subjects between the ages of 19-50 years with chronic urticaria seen within the UNMC Allergy Clinics will be invited to be enrolled.

Based on this trial design, predict the completion outcome and termination type (if applicable).